Keigo Yorozu
- Oncology top 5%
- HER2/EGFR in Cancer Research 11
- Colorectal Cancer Treatments and Studies 7
- Cancer Immunotherapy and Biomarkers 5
- Cancer Treatment and Pharmacology 5
- Hematology top 10%
- Erythropoietin and Anemia Treatment 6
- Iron Metabolism and Disorders 6
- Genetics top 10%
- Hemoglobinopathies and Related Disorders 6
-
- Monoclonal and Polyclonal Antibodies Research 7
- Co-authors
- Mitsue KurasawaKoh FurugakiKaori Fujimoto-OuchiYoriko Yamashita‐KashimaMieko YanagisawaToshiki IwaiMasamichi SugimotoKaname Yamamoto
- Partner nations
- United StatesJapanSwitzerland
In The Last Decade
Keigo Yorozu
50 papers receiving 983 citations
Peers
Comparison fields: 5 of 80
- Oncology 566
- Hematology 113
- Pulmonary and Respiratory Medicine 289
- Genetics 91
- Radiology, Nuclear Medicine and Imaging 176
Countries citing papers authored by Keigo Yorozu
This map shows the geographic impact of Keigo Yorozu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keigo Yorozu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keigo Yorozu more than expected).
Fields of papers citing papers by Keigo Yorozu
This network shows the impact of papers produced by Keigo Yorozu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keigo Yorozu. The network helps show where Keigo Yorozu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keigo Yorozu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 9 | |
| 4 | 2022 | 2 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 13 | |
| 7 | 2019 | 25 | |
| 8 | 2017 | 6 | |
| 9 | 2017 | 21 | |
| 10 | 2016 | 14 | |
| 11 | 2016 | 20 | |
| 12 | 2016 | 9 | |
| 13 | 2014 | 11 | |
| 14 | 2014 | 33 | |
| 15 | 2012 | 44 | |
| 16 | 2003 | 20 | |
| 17 | 2002 | 112 | |
| 18 | 2002 | 13 | |
| 19 | 1997 | 23 | |
| 20 | 1991 | 1 |
About Keigo Yorozu
Keigo Yorozu is a scholar working on Oncology, Genetics and Immunology and Allergy, having authored 52 papers that have together received 1.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Erythropoietin and Anemia Treatment (6 papers), Iron Metabolism and Disorders (6 papers), Hemoglobinopathies and Related Disorders (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Oncology (566 citations), Hematology (113 citations) and Pulmonary and Respiratory Medicine (289 citations). Keigo Yorozu has collaborated with scholars based in United States, Japan and Switzerland. Frequent co-authors include Mitsue Kurasawa, Koh Furugaki, Kaori Fujimoto-Ouchi, Yoriko Yamashita‐Kashima, Mieko Yanagisawa, Toshiki Iwai, Masamichi Sugimoto, Kaname Yamamoto, Yoichiro Moriya and Masateru Ohta. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.